SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 198 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20 | -80.8% | 35,051 | -56.2% | 0.00% | – |
| Q2 2023 | $104 | +395.2% | 80,078 | +536.1% | 0.00% | – |
| Q1 2023 | $21 | -72.0% | 12,589 | -48.0% | 0.00% | – |
| Q4 2022 | $75 | -99.9% | 24,210 | -10.2% | 0.00% | – |
| Q3 2022 | $131,000 | +18.0% | 26,964 | +0.2% | 0.00% | – |
| Q2 2022 | $111,000 | +58.6% | 26,919 | +121.2% | 0.00% | – |
| Q1 2022 | $70,000 | +7.7% | 12,168 | +37.9% | 0.00% | – |
| Q4 2021 | $65,000 | 0.0% | 8,826 | +21.5% | 0.00% | – |
| Q3 2021 | $65,000 | -66.3% | 7,266 | -55.3% | 0.00% | – |
| Q2 2021 | $193,000 | +9550.0% | 16,256 | +7092.9% | 0.00% | – |
| Q1 2021 | $2,000 | -97.6% | 226 | -95.8% | 0.00% | – |
| Q4 2020 | $83,000 | – | 5,347 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Golden State Equity Partners | 154,360 | $897,000 | 0.45% |
| Rhenman & Partners Asset Management AB | 761,429 | $4,424,000 | 0.44% |
| Lombard Odier Asset Management (Switzerland) SA | 860,702 | $5,001,000 | 0.39% |
| WASATCH ADVISORS LP | 10,576,997 | $61,452,000 | 0.30% |
| Rokos Capital Management LLP | 977,663 | $5,861,000 | 0.27% |
| KLK CAPITAL MANAGEMENT LLC | 44,323 | $258,000 | 0.26% |
| Long Focus Capital Management, LLC | 340,000 | $1,975,000 | 0.25% |
| Vanguard Capital Wealth Advisors | 33,380 | $193,000 | 0.14% |
| Fort Sheridan Advisors LLC | 73,978 | $430,000 | 0.13% |
| Delphia (USA) Inc. | 20,983 | $122,000 | 0.09% |